X4 Pharmaceuticals (XFOR) Other Non-Current Assets (2017 - 2026)

X4 Pharmaceuticals (XFOR) has reported Other Non-Current Assets for 10 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 27.28% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (up 27.28% YoY), and the FY2025 full-year result was $692000.0, down 66.73% from the prior year.
• Other Non-Current Assets rose to $3.0 million in Q2 2026 per XFOR's latest filing, from $704000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q1 2025 and bottomed at $692000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $1.7 million across 5 years, with a median of $1.6 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets surged 101.94% in 2025, then sank 76.63% in 2026.
• Over 5 years, Other Non-Current Assets stood at $1.2 million in 2022, then advanced by 17.22% to $1.4 million in 2023, then soared by 44.85% to $2.1 million in 2024, then slumped by 66.73% to $692000.0 in 2025, then jumped by 332.23% to $3.0 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $3.0 million, $704000.0, and $692000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.